These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 36439170)

  • 1. Hypersensitivity reactions to small molecule drugs.
    Han J; Pan C; Tang X; Li Q; Zhu Y; Zhang Y; Liang A
    Front Immunol; 2022; 13():1016730. PubMed ID: 36439170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms.
    Pichler WJ; Hausmann O
    Int Arch Allergy Immunol; 2016; 171(3-4):166-179. PubMed ID: 27960170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune pathomechanism and classification of drug hypersensitivity.
    Pichler WJ
    Allergy; 2019 Aug; 74(8):1457-1471. PubMed ID: 30843233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
    Gerber BO; Pichler WJ
    AAPS J; 2006 Mar; 8(1):E160-5. PubMed ID: 16584124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interaction of drugs with immune receptors: the p-i concept.
    Pichler WJ; Beeler A; Keller M; Lerch M; Posadas S; Schmid D; Spanou Z; Zawodniak A; Gerber B
    Allergol Int; 2006 Mar; 55(1):17-25. PubMed ID: 17075282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions.
    Mayorga C; Montañez MI; Jurado-Escobar R; Gil-Ocaña V; Cornejo-García JA
    Curr Pharm Des; 2019; 25(36):3813-3828. PubMed ID: 31692430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune pathomechanism of drug hypersensitivity reactions.
    Pichler WJ; Naisbitt DJ; Park BK
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
    Chen CB; Abe R; Pan RY; Wang CW; Hung SI; Tsai YG; Chung WH
    J Immunol Res; 2018; 2018():6431694. PubMed ID: 29651444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.
    Pichler WJ
    Allergy; 2022 Feb; 77(2):404-415. PubMed ID: 34037262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral infections and drug hypersensitivity.
    Pichler WJ; Brüggen MC
    Allergy; 2023 Jan; 78(1):60-70. PubMed ID: 36264263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed drug hypersensitivity: models of T-cell stimulation.
    Adam J; Pichler WJ; Yerly D
    Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug hypersensitivity reactions: pathomechanism and clinical symptoms.
    Pichler WJ; Adam J; Daubner B; Gentinetta T; Keller M; Yerly D
    Med Clin North Am; 2010 Jul; 94(4):645-64, xv. PubMed ID: 20609855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed drug hypersensitivity reactions - new concepts.
    Posadas SJ; Pichler WJ
    Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonclinical Tools to Assess Risk of Drug Hypersensitivity Reactions.
    Whritenour J; Casinghino S; Collinge M; Zhu X
    Annu Rev Pharmacol Toxicol; 2016; 56():561-76. PubMed ID: 26514195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation in drug allergies.
    Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M
    Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug hypersensitivity reactions involving skin.
    Hausmann O; Schnyder B; Pichler WJ
    Handb Exp Pharmacol; 2010; (196):29-55. PubMed ID: 20020258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular aspects of drug recognition by specific T cells.
    Britschgi M; von Greyerz S; Burkhart C; Pichler WJ
    Curr Drug Targets; 2003 Jan; 4(1):1-11. PubMed ID: 12528985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.